Treatment of NEonatal seizures with Medication Off-patent: evaluation of efficacy and safety of bumetanide
Neonatal hypoxic ischaemic encephalopathy (HIE) occurs in 2-3/1000 live births and is a major cause of both acute mortality and long-term neurodisability. Seizures are the hallmark of HIE.
See more:
Short name and number:
NEMO (241479)
Name of US Partner:
DUKE UNIVERSITY
Contact:
UNIVERSITY COLLEGE LONDON
Participating Countries:
United States
Area:
Health
Category:
FP7 Project with U.S. partner
